Anti‐RBP4 mAb could be used to detect the RBP4 expression level by immunohistochemistry (IHC) on the basis of the expression level of RBP4 in HCC tissues found on The Cancer Genome Atlas (TCGA) database. The gene discussed is RBP4; the disease is hepatocellular carcinoma.